Group items tagged

North America accounted for the largest influenza vaccine market share in 2020 and is expected to retain its dominance throughout the forecast period. This is attributed to the increased prevalence of influenza in the region, increase in government focus on immunization programs, emergence of new vaccines, and growth in technological advancements for vaccine administration.

It is also important to realize that although malaria vaccines have come a long way in terms of safety and effectiveness, they still have some risks.

US regulators have recently confirmed that the Pfizer/BioNTech COVID vaccine is 95 percent effective, and have approved it for emergency use.

39% of the hospitals throughout the country will have negative operating margins during the most optimistic COVID-19 scenario.

The global immunotherapy drugs market will continue to grow, owing to increasing incidence of lifestyle-related and chronic disease globally, increasing product approvals, rising healthcare expenditures, and increasing access to better diagnostic & treatment facilities. High preference for immunotherapy over traditional chemotherapy and its use in combination with the same in first-line treatments coupled with high adoption of targeted therapies is expected to support the market growth during the forecast period 2019-2025. The immunotherapy drugs market, by type of drug, is segmented into monoclonal antibodies (mAbs), vaccine, non-specific immunotherapies, adaptive cell therapy, and others. Among these, monoclonal antibodies occupied a significant share in 2018 while the fastest growing type was adaptive cell therapy, which is expected to grow at a high CAGR during the forecast period 2019-2025. Increased preference for mAbs with fewer side-effects made this type the dominant market shareholder in 2018.

The factors such as single treatment for minor or simple infections, inadequate infrastructures, and disinclination for the treatment in retail clinics are the factors that hinder the growth potential of the market. North America has the largest share in the retail clinics market to date, this is because of the preference of the retail clinic as they are a highly efficient and cost-effective market. Whereas Europe is continuously growing which is due to the growing emphasis on preventive care and direct hospitalization.